tldrdailynews.com logo

GSK Commits $30 Billion Investment in U.S. Amid Political and Industry Challenges

1 min read
Source: CNBC
GSK Commits $30 Billion Investment in U.S. Amid Political and Industry Challenges
Photo: CNBC
TL;DR

GSK announced a $30 billion investment in U.S. research, development, and manufacturing over five years, including $1.2 billion for advanced manufacturing and digital tech, amid President Trump's UK visit, reflecting increased U.S. pharma investments.

Topics:top-newsbusiness#business#gsk#pharmaceuticals#randd#trump-visit#us-investment
Share this article
  1. UK's GSK announces $30 billion U.S. pharma investment amid Trump state visit  CNBC
  2. GSK plans $30 billion US investment as pharma tariff threat looms  Reuters
  3. GSK pumps $30bn into America after pressure from Trump  The Times
  4. GSK to invest $30 billion in R&D and Manufacturing in the United States over next 5 years  GSK
  5. GSK pledges $30bn US investment as UK's pharma woes deepen  BBC

Want the full story? Read the original reporting

Read on CNBC